Prot# NU 07B1: A Double-Blind, Randomized Phase 2b Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo When Administered in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Breast Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date5/25/077/1/13

Funding

  • Onyx Pharmaceuticals, Inc. (NU 07B1)